Blanchard-Bregeon; Veronique
Patent Applications and Registrations
Patent applications and USPTO patent grants for Blanchard-Bregeon; Veronique.The latest application filed is for "h3 receptor antagonist for use in the treatment of alzheimer's disease".
- Blanchard-Bregeon; Veronique - Paris FR
| Patent | Date |
|---|---|
| H3 receptor antagonist for use in the treatment of alzheimer's disease Grant 9,789,102 - Barneoud , et al. October 17, 2 | 2017-10-17 |
| H3 Receptor Antagonist For Use In The Treatment Of Alzheimer's Disease App 20160101099 - BARNEOUD; Pascal ; et al. | 2016-04-14 |
| An H3 Receptor Antagonist For Use In The Treatment Of Alzheimer's Disease App 20150031893 - BARNEOUD; Pascal ; et al. | 2015-01-29 |
| Antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs Grant 8,343,493 - VanMechelen , et al. January 1, 2 | 2013-01-01 |
| Antibodies Specific Of The Beta-amyloid Peptides And Their Uses As Diagnostic Agents Or Drugs App 20110059092 - Vanmechelen; Eugeen ; et al. | 2011-03-10 |
| Transgenic animals exhibiting major disorders related to Alzheimer's disease Grant 7,700,823 - Casas Louzao , et al. April 20, 2 | 2010-04-20 |
| Transgenic animals exhibiting major disorders related to Alzheimer's disease App 20050076400 - Casas Louzao, Caty ; et al. | 2005-04-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 